Health
Common diabetes drug can reduce risk of major heart issues – TheHealthSite
SGLT2 inhibitors prescribed for diabetes can reduce the risk of heart conditions such as heart attack stroke and heart failure compared with placebo.
Drugs known as sodium-glucose cotransporter 2 (SGLT2) inhibitors are associated with a lower risk of major heart problems in patients with type 2 diabetes than dipeptidyl peptidase-4 (DPP-4) inhibitors, say, researchers. According to the study, published in the journal The BMJ, previous trials have shown that SGLT2 inhibitors can reduce the risk of heart conditions such as heart attack, stroke, and heart failure compared with placebo. But some of these trials had important limitations, making it…
-
Noosa News12 hours agoTeenage girl dies in hit-and-run, police hunt for ute
-
Noosa News7 hours agoArnie the dog found dead in stolen ute after week of searching
-
Noosa News14 hours agoTeenage girl killed in alleged hit-and-run at Margate north of Brisbane
-
Noosa News7 hours ago‘Beyond devastated’ Brisbane family learn missing German shepherd Arnie found dead in back of stolen car